baber/WOPTO huggingface dataset:
Patent NZ-509944-A (NZ)
Title: A display deck for merchandise
Inventor: DARROCH ROBERT JOHN
IPC: A47F5/10
Filed: 1999-08-12
Abstract: The display deck (10) is for use in produce/product display cabinets of the type typically used in supermarkets and delicatessens and the like. The display deck (10) is comprised of a series of elongate strips (12) pivotally joined together at their longitudinal edges and supported by profiled support elements (18) which may be substituted by alternatively profiled support elements suitable for displaying alternative produce/product lines. The display cabinet may be refrigerated, chilled, heated or standard and may include additional features such as misting devices/humidifiers.
Patent NZ-509960-A (NZ)
Title: Bipolar electrode for electrochemical redox reactions
Inventor: ZOCCHI ANDREA
IPC: H01M8/02
Filed: 1999-07-01
Abstract: Carbon-base bipolar electrode for electrochemical redox reactions in an acid electrolyte in the form of a fluid impervious and electrically conductive septum, at least a face of which consists, at least partially, of a fluid previous woven or unwoven electrodically active fabric of carbon fibres or of yarns of carbon fibres, has an electrically conductive fluid impervious septum consisting of a composite of a matrix fabric (M) in the form of a tightly knit or woven fabric (1) of carbon fibres or of yarns of carbon fibres the pores of which are hydraulically sealed by an electrically conductive carbon containing material at least partly filling the pores of said matrix fabric. The carbon containing electrically conductive material may be a glassy carbon formed in situ by thermal conversion of a precursor material with which said matrix fabric is pre-impregnated or a polymerised thermosetting resin loaded with carbon and/or graphite particles and/or fibres or a thermally reflown aggregate of a thermoplastic resin an carbon and/or graphite particles and/or fibres. The pervious fabric on the face of the electrode may be a raised pile of carbon fibres
Patent NZ-512589-A (NZ)
Title: Method and polynucleotides for determining translational efficiency of a codon
Inventor: FRAZER IAN HECTOR
IPC: C12Q1/68
Filed: 2000-01-07
Abstract: A method is disclosed for determining the translational efficiency of an individual codon in a cell. The method comprises introducing into the cell a synthetic construct comprising a reporter polynucleotide fused in frame with a tandem repeat of said individual codon, wherein said reporter polynucleotide encodes a reporter protein, and wherein said synthetic construct is operably linked to a regulatory polynucleotide and measuring expression of said reporter protein in said cell to determine the translational efficiency of said codon.
Patent NZ-515283-A (NZ)
Title: Locking system, floorboard comprising such a locking system, as well as method for making floorboards
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2000-04-26
Abstract: The invention relates to a locking system for mechanical joining of floorboards (1) constructed from a body (30), a rear balancing layer (34), and an upper surface layer (32). A strip (6), which is integrally formed with the body (30) of the floorboard and which projects from a joint plane (F) and under an adjoining board (1), has a locking element (8) which engages a locking groove (14) in the rear side of the adjoining board. The joint edge provided with the strip (6) is modified with respect to the balancing layer (34), for example by means of machining of the balancing layer under the strip (6), in order to prevent deflection of the strip (6) caused by changes in relative humidity. The invention also relates to a floorboard provided with such a locking system, as well as a method for making floorboards with such a locking system.
Patent NZ-517205-A (NZ)
Title: Curd block former tower with micropeened inner surface
IPC: A01J25/11
Filed: 2002-02-14
Abstract: Stainless steel structural member for a blockformer installation (1), which structural member has at least one surface along which in operation curd slides (such as the inner surface of the drainage tube(4)). The surface, coming into contact with curd is partly a sloping undulating surface (40-43), viewed on a microscopic scale in Figure 3, which has been obtained through a micropeening treatment. This differs from the usual known surfaces (29-33) shown in Figure 2, which is a result of traditional treatments (grinding, polishing).
Patent NZ-521889-A (NZ)
Title: Bearing housing and roller shaft seal with flexible sealing arrangement to absorb relative axial movement
Inventor: DYSON KINGLSEY BRUCE
IPC: F16C33/76
Filed: 2001-04-11
Abstract: Moulded  plastics  bearing  housing  (10),  receiving rolling  bearing  (26), is press-fitted  into  end  (72)  of conveyor  roller  tube (74). Body portion  (12)  of  housing (10)   extends   radially  inward  as  neck   portion   (46) terminating  in  two  rims, one sealing against  shaft  (82) supporting  the  conveyor  roller  and  the  other   sealing against  inner race (30) of bearing (26). Both sealing  rims are  curved  in section so as to make low angles with  shaft (82)  and  bearing  (26). The flexibility  of  this  sealing arrangement absorbs axial movements between shaft  (82)  and the roller.
Patent NZ-521976-A (NZ)
Title: Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
Inventor: CHOW ALAN Y
IPC: A61N1/05
Filed: 2001-05-01
Abstract: An artificial retina device for electrically stimulating a neuroretina of an eye to produce artificial vision comprises: an electrical source; at least one stimulating electrode connected with the electrical source and at least one ground return electrode connected with the electrical source, wherein the stimulating electrode and ground return electrode are configured to be disposed within the eye on opposite sides of the neuroretina.
Patent NZ-523071-A (NZ)
Title: Liquid heating system
Inventor: HALE GEORGE GERALD
IPC: F25B30/06
Filed: 2002-12-09
Abstract: A method and apparatus for heating a liquid to a temperature in the range of from 60 to 90°C which comprises or includes passing that liquid in a non mingling heat exchange with a working fluid such that a heat exchange occurs initially which allows uptake by the liquid of at least some of the latent heat of the working fluid and thereafter another heat exchange which allows the uptake of all of the superheat from the working fluid, the heat exchangers being part of a heat pump system deriving its input heat by a first heat exchange. The heating system comprised a first heat exchanger adapted to extract heat from a fluid or other source, a heat pump system having a circulating second working fluid adapted to extract heat via the first heat exchanger, the heat pump system including downstream of the heat pump system compressor two heat exchangers in series ("second heat exchanger" and "third heat exchanger" respectively"), the third heat exchanger feeding the second working fluid back to the second heat exchanger, and a water system adapted to feed water to be heated first through the second heat exchanger and then through the third heat exchanger and from then as heated water, to an off take or to storage, wherein the third heat exchanger heats the water with superheat of the vapour of the second working fluid, and wherein the second heat exchanger floods downwardly with the condensed/condensing vapour of the second working fluid thereby heating water with sensible and/or latent heat.
Patent NZ-525228-A (NZ)
Title: Tobacco smoke filter having copper-containing porphyrin bound to the cellulose fiber
Inventor: LESSER CRAIG A
IPC: A24B15/30
Filed: 2001-09-04
Abstract: A tobacco smoke filter comprising an iron analog of C.I. Reactive Blue 21 dye.
Patent NZ-527824-A (NZ)
Title: Thin and highly flexible transdermal therapeutic system (TTS) comprising nicotine and. where appropriate, other active ingredients which act on the nervous system
Inventor: BRACHT STEFAN
IPC: A61K47/32
Filed: 2002-02-19
Abstract: Described are transdermal therapeutic systems (TTS) having nicotine as active substance, which are characterised by a particularly high flexibility. The flexibility decisively improves carrying comfort on the skin due to the fact that the system can easily adapt to the surface of the skin and its continuous movement. The nicotine TTS according described is clearly more flexible than leading nicotine TTS products currently available in the market although at least some of the other systems are equally as thin.
Patent NZ-528152-A (NZ)
Title: Method for producing cytokinin synthase and uses thereof
Inventor: KAKIMOTO TATSUO
IPC: C12N15/52
Filed: 2002-03-12
Abstract: Disclosed is a method for producing cytokinin synthase comprising: culturing or growing a plant or plant cells transformed by a vector comprising a promoter and a cytokinin synthase gene, and harvesting the cytokinin synthase from said host; wherein said cytokinin synthase gene is: (a) a gene which encodes a protein having cytokinin synthesis activity and an amino acid sequence described in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14; or (b) a gene which encodes a protein having cytokinin synthesis activity and which has a modified amino acid sequence resulting from the addition and/or deletion of one or 50 or less amino acids and/or substitution by 100 or less amino acids in SEQ ID NO. 2, 4, 6, 8, 10, 12 or 14; or (c) a gene which hybridizes with a nucleic acid having a nucleotide sequence described in SEQ ID NO. 1, 3, 5, 7, 9, 11 or 13 under highly stringent conditions, and which encodes a protein having cytokinin synthesis activity. Also disclosed is a method for regulating plant growth using the described cytokinin synthase gene, and methods for searching for a plant gene that encodes an isopentenyl group transferase based on homology with a disclosed amino acid sequence.
Patent NZ-528659-A (NZ)
Title: A drug for use in bone grafting
Inventor: LITTLE DAVID GRAHAM
IPC: A61K35/28
Filed: 2002-03-28
Abstract: A drug and method of bone grafting which improves the osteoinductive and/or osteoconductive potential of a bone graft, bone graft substitute or extenders are ascribed. The drug is selected from the group consisting of bisphosphonates which may be administered to a subject either prior to, during or after a bone grafting procedure.
Patent NZ-532165-A (NZ)
Title: Microbiocidal aqueous formulation comprising essential oils or their derivatives
Inventor: BEN-YEHOSHUA SHIMSHON
IPC: A23B7/153
Filed: 2002-10-03
Abstract: A microbiocidal aqueous formulation is disclosed, which comprises: (i) an effective amount of at least one essential oil component, or derivatives thereof, said derivatives thereof obtained by exposure to light or by oxidation, or mixtures thereof; and (ii) at least one additional stabilizer selected from the group consisting of ethanol in an amount of from 10% to about 50%, an emulsifier, an antioxidant, or an encapsulating agent. A method for inhibiting microbial development using this microbiocidal aqueous formulation is also disclosed.
Patent NZ-541236-A (NZ)
Title: Apparatus and method for storing proteins
Inventor: KNIGHT DAVID PHILIP
IPC: D01D1/02
Filed: 2003-12-23
Abstract: An apparatus for the storage of a protein (20) comprising a first compartment (30) for storing the protein (20) and a second compartment (40) for storing an alkaline buffer (50), the second compartment (40) being in fluid communication with the first compartment (30) is described. In one preferential embodiment of the invention, the alkaline buffer comprises calcium ions which encourage the gelling of the protein (20). A method for the storage of a protein (20) is also described. The method comprises: a first step of placing the protein in a first storage compartment (30); a second step of exposing the protein (20) to an alkaline buffer (50); and a third step of maintaining the protein (20) in the alkaline atmosphere in the first storage compartment (30).
Patent NZ-542634-A (NZ)
Title: High intensity discharge lamp control with primary current via fixed ballast and a secondary current injected by a control unit to provide required total lamp current based on monitored lamp parameters
Inventor: DLUZNIAK RICHARD
IPC: H05B41/392
Filed: 2004-05-07
Abstract: A controller for a high intensity discharge lamp includes a primary ballast for providing a primary current to the lamp, and a current injector which in the case shown comprises a control ballast and a switch (e.g. a triac) controlled by a control unit. The current injector injects a secondary current into the lamp that is less than the primary current and can be varied by the control unit, e.g. by varying the amount of time within an AC cycle that the control ballast is switched into the circuit. The controller allows the lamp to be controlled, for example, to operate at a constant power (variable light output) or at a constant light output (variable power).
Patent NZ-543998-A (NZ)
Title: Surgical nail
Inventor: SCHLIENGER ANDRE
IPC: A61B17/72
Filed: 2003-06-12
Abstract: A surgical nail (1), in the form of an intramedullary nail with a central axis (2), consisting of a material M with a tensile strength Fz, compressive strength Fd, density rho 2 and an elasticity modulus E. The nail comprises at least one transversal bore (5), which runs transversally to the central axis and has a cross-sectional profile F, and a transversal axis (6), the cross-sectional profile F having a maximum length (a) that runs in the direction of the central axis and a maximum width (b) that runs perpendicular to the length. The nail also comprises a longitudinal bore (3) running coaxially with the central axis and a wall (4), in addition to an insert (7) that can be introduced into the region of the transversal bore via the longitudinal bore. The insert has a longitudinal axis (13) and consists of a material "m", which has a lower elasticity modulus e < E than the material M.
Patent NZ-545341-A (NZ)
Title: Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food
Inventor: YAMAMOTO NAOYUKI
IPC: A23L1/305
Filed: 2004-07-30
Abstract: Disclosed is the use of a peptide having Pro at a carboxyl terminal, selected from the group consisting of Gln-Pro, Met-Pro, and Ser-Pro-Pro, or a salt thereof in the manufacture of a medicament or a functional food for reducing blood pressure.
Patent NZ-553204-A (NZ)
Title: Formulations of suberoylanilide hydroxamic acid and methods for producing same
Inventor: WONG JEANNIE CHOW
IPC: A61K31/00
Filed: 2006-05-16
Abstract: Provided is a process of producing a pharmaceutical composition comprising crystalline suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof, comprising the steps of: (a) blending 60-5% of a first batch of crystalline suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof having a mean particle size of less than 60 micrometers and 40-95% of a second batch of crystalline suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof having a mean particle size of 100-250 micrometers; and (b) encapsulating a portion of the blended crystalline suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof to produce the pharmaceutical composition.
Patent NZ-553725-A (NZ)
Title: Method for production of disposable absorbent articles
Inventor: HERMANSSON KENT
Filed: 2004-09-29
Abstract: A method for production of disposable hygienic absorbent articles 10, each article 10 comprising: a substantially homogenous elastic laminate web 14 having a maximum elastic extensibility in a first direction of at least 40%, under a peak load Fp, and an absorbent core 16 attached to the elastic laminate web 14, the method comprising the steps of: providing a continuous length of the elastic laminate web 14; advancing the continuous length of the elastic laminate web 14 in a direction of travel corresponding to the first direction; attaching individual absorbent cores 16 to the continuous length of the elastic laminate web 14 at spaced intervals, and forming individual articles from the thus assembled individual absorbent cores 16 and the continuous length of the elastic laminate web 14, whereby the continuous length of the elastic laminate web 14 is maintained under a tensioning load Ft in the direction of travel during the advancing, the tensioning load Ft satisfying the condition: 0.03 Fp < Ft < 0.25 Fp.
Patent NZ-554093-A (NZ)
Title: Anti-cancer combinations of DMXAA and known anticancer drugs
Inventor: WILSON WILLIAM ROBERT
IPC: A61K33/243
Filed: 2002-09-03
Abstract: Disclosed are synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) or a pharmaceutically acceptable salt or ester thereof and a topoisomerase I inhibitor, in particular irinotecan, and the use of the combination in the treatment of cancer and pharmaceutical compositions containing said combinations. Also disclosed are synergestic combinations of DMXAA or a pharmaceutically acceptable salt or ester thereof and doxorubicin, wherein the combination does not include an antibody, and the use of the combination in the treatment of cancer and pharmaceutical compositions containing said combinations.
Patent NZ-554442-A (NZ)
Title: Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
Inventor: CHUN BYOUNG-KWON
IPC: A61K31/7072
Filed: 2005-09-13
Abstract: Disclosed is a process for the preparation of a 2-C-alkyl-2-deoxy-2-substituted-D-ribofuranose of formula 49B comprising: wherein R2 is independently hydrogen, an alkyl, hydroxymethyl, methoxymethyl, halomethyl vinyl, halovinyl, ethynyl, haloethynyl, allyl, or haloallyl; R3 is independently a alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl, or haloallyl; R5, R6 are independently H, ethoxymethyl, benzyloxymethyl (BOM), acetyl, benzoyl, pivaloyl, 2-, 3-, or 4-nitrobenzoyl, 2-, 3-, or 4-chlorobenzoyl, or toluoyl; and Nu is F, Cl, N3, CN, NO3, CF3, SCN, OR or NR2 where R is independently acyl, arylalkyl, an alkyl, or CH2R where R is hydrogen, or an alkyl; (a) treating a compound of formula 51B or 52B: with an acid in at least one solvent, (b) optionally, followed by azeotropic distillation in benzene or toluene in presence of acid to provide a compound of formula 53B; and (c) protection of a compound of formula 53B with a protecting agent, and a base in a solvent. Also disclosed are intermediate 2-alkyl4,5-di-O-protected-2,3-dihydroxy-pentanoic-acid fluorinated sulphate esters 51B and 52B.
Patent NZ-556717-A (NZ)
Title: Pharmaceutical compositons useful in the transmucosal administration of drugs using microparticles attached to the surface of larger carrier particles
Inventor: FRANSEN NELLY
IPC: A61K9/14
Filed: 2006-02-10
Abstract: Disclosed is a pharmaceutical composition in the form of a homogeneous interactive mixture, comprising a pharmacologically-effective amount of an active ingredient in the form of microparticles of a size of 0.5-10 micrometres, which particles are attached to the surfaces of larger carrier particles with a size range of 10-100 micrometres, wherein the total amount of active ingredient that is present is in the range about 0.05 to about 5% by weight based upon the total weight of the composition and wherein the carrier particles are bioadhesive and/or mucoadhesive in their nature. Also disclosed is a process for preparing the above composition, and the use of the composition in treating diseases which the active ingredient is suitable for use against.
Patent NZ-560666-A (NZ)
Title: Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
Inventor: CAROTTI ANGELO
IPC: C07D311/58
Filed: 2006-02-22
Abstract: Disclosed are aminoalkyl- and amidoalkyl-benzopyran derivatives of formula (I) and the pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. These compounds are active as selective and reversible monoamine oxidase type B (MAO-B) inhibitors in vitro and in vivo and are suitable for the prevention and treatment of CNS degenerative disorders including Parkinson's disease, Alzheimer's disease, restless leg syndrome, epilepsy, amylotrophic lateral sclerosis, stroke, attention deficit hyperactivity disorders, drug addiction, smoking cessation or obesity.
Patent NZ-561210-A (NZ)
Title: Spiro-oxindole compounds and their uses as therapeutic agents
Inventor: CHOWDHURY SULTAN
IPC: A61K31/404
Filed: 2006-04-11
Abstract: The disclosure relates to spiro-oxindole compounds of formula (I), as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or an acetate, formate or benzoate derivative of any alcohol functional group or an amide derivative of any amine functional group thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising these spiro-oxindole compounds and methods of preparing and using the compounds are also disclosed.
Patent NZ-561525-A (NZ)
Title: Benzimidazole compounds and analogues, containing a pyrazole ring, for inhibition of Trk activity, affecting cancer
Inventor: LAMB MICHELLE
IPC: A61K31/4155
Filed: 2006-02-15
Abstract: Disclosed is a pyrazole derivative, including a benzimidazole or an analog there of, of formula (I), wherein each X is N or CR10, A is a bond or optionally substituted C1-2alkylene, C is a carbocyclyl or heterocyclyl, optionally substituted, and wherein the other substituents are as defined in the specification. Also disclosed is a process for preparing the above compound, and the use of the compound for inhibiting Trk activity, such as in the treatment of cancer.